Data / Drug companies / L'bri Health & Beauty
L'bri Health & Beauty: 12 products in the FDA NDC directory, labeler code 71238
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
L'bri Health & Beauty (labeler code 71238) lists 12 products in the FDA National Drug Code Directory, covering 6 finished drugs by generic name. By type: 12 over the counter drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on June 23, 2026.
The request: Watch L'bri Health & Beauty (FDA labeler code 71238): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 71238
- Products in commercial distribution
- 12
- Packages
- 15
- Finished drugs by generic name
- 6
- Prescription products
- 0
- Over the counter products
- 12
- Flagged as original packager
- 12 of 12 products that carry the flag
- Started marketing in the last 12 months
- 4
- Earliest marketing start
- February 7, 2017
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 12 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Over the counter drugs | 12 | 100% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Octocrylene, zinc oxide | 4 | 11 |
| Salicylic acid | 4 | 330 |
| Zinc oxide | 1 | 595 |
| Octinoxate, avobenzone, octisalate | 1 | 2 |
| Methyl salicylate, menthol, capsaicin | 1 | 6 |
| Menthol, methyl salicylate | 1 | 36 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Cream | 8 | 66.7% |
| Liquid | 2 | 16.7% |
| Lotion | 2 | 16.7% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
| Class | Products |
|---|---|
| Copper Absorption Inhibitor | 5 |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| L BRI Deep Clean Toner | 71238-921 | Liquid | Over the counter monograph drugs | June 23, 2026 |
| L BRI Klearaway | 71238-922 | Lotion | Over the counter monograph drugs | June 4, 2026 |
| L Bri CC DD Color Correcting Daily Defense Sunscreen SPF 30 Medium | 71238-926 | Cream | Over the counter monograph drugs | November 23, 2025 |
| L Bri CC DD Color Correcting Daily Defense Sunscreen SPF 30 Medium Dark | 71238-914 | Cream | Over the counter monograph drugs | November 23, 2025 |
| L Bri CC DD Color Correcting Daily Defense Sunscreen SPF 30 Light | 71238-580 | Cream | Over the counter monograph drugs | December 30, 2024 |
| L Bri CC DD Color Correcting Daily Defense Sunscreen SPF 30 Light Medium | 71238-579 | Cream | Over the counter monograph drugs | December 30, 2024 |
| LBRI PURE n NATURAL KlearAway | 71238-464 | Lotion | Over the counter monograph drugs | March 4, 2024 |
| LBRI STOP THE PAIN Super Aloe Pain Relief Cream | 71238-492 | Cream | Over the counter monograph drugs | June 19, 2023 |
| L BRI Pure n Natural Deep Clean Toner | 71238-218 | Liquid | Over the counter monograph drugs | September 1, 2021 |
| LBri Pure n Natural SPF 30 | 71238-326 | Cream | Over the counter monograph drugs | May 1, 2018 |
| LBri Super Aloe Stop The Pain | 71238-847 | Cream | Over the counter monograph drugs | October 3, 2017 |
| LBri Pure nNatural Oil Free Moisturizer | 71238-785 | Cream | Over the counter monograph drugs | February 7, 2017 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.